Literature DB >> 16493002

Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago.

Ariella Zivelin1, Ronit Mor-Cohen, Victoria Kovalsky, Nurit Kornbrot, Jacqueline Conard, Flora Peyvandi, Paul A Kyrle, Rogier Bertina, Ferial Peyvandi, Joseph Emmerich, Uri Seligsohn.   

Abstract

Prothrombin 20210G>A and factor V Leiden are common prothrombotic mutations in whites for which founder effects have been established. In this study, we analyzed the frequencies of 5 single nucleotide polymorphisms (SNPs) and 9 microsatellites flanking the prothrombin gene (F2) in 88 homozygotes for 20210A and 66 homozygotes for 20210G. For estimating the age of the prothrombin 20210G>A mutation, we used the DMLE+2.0 program, which analyzed linkage disequilibria between the mutation and the multiple markers that had been assessed. This analysis yielded an age estimate of 23,720 years (95% credible set, 19,080-31,340 years). A similar analysis by the DMLE+2.0 program was performed on 5 SNPs from previously studied homozygotes for factor V Leiden and controls that yielded an age estimate of 21,340 years (95% credible set, 16,880-29,480 years). The occurrence of the 2 mutations in whites toward the end of the last glaciation and their presently wide distribution in whites suggest selective evolutionary advantages for which some evidence was reported (diminished blood loss) or is controversial (protection against infections).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493002     DOI: 10.1182/blood-2005-12-5158

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  The hemostatic balance revisited through the lessons of mankind evolution.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2008-02-19       Impact factor: 3.397

2.  Mankind adaptation and present human health.

Authors:  Franco Contaldo; Salvatore Auricchio
Journal:  Intern Emerg Med       Date:  2008-06-25       Impact factor: 3.397

3.  The distribution of Factor V Leiden mutation.

Authors:  Aydan Eroğlu
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

4.  Framing postpartum hemorrhage as a consequence of human placental biology: an evolutionary and comparative perspective.

Authors:  Elizabeth T Abrams; Julienne N Rutherford
Journal:  Am Anthropol       Date:  2011

5.  A likelihood model that accounts for censoring due to fetal loss can accurately test the effects of maternal and fetal genotype on the probability of miscarriage.

Authors:  Colin I O'Donnell; Charles J Glueck; Tasha E Fingerlin; Deborah H Glueck
Journal:  Hum Hered       Date:  2008-10-17       Impact factor: 0.444

6.  MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events.

Authors:  Stefan Aretz; Rossella Tricarico; Laura Papi; Isabel Spier; Elisa Pin; Sukanya Horpaopan; Emanuela Lucci Cordisco; Monica Pedroni; Dietlinde Stienen; Annamaria Gentile; Anna Panza; Ada Piepoli; Maurizio Ponz de Leon; Waltraut Friedl; Alessandra Viel; Maurizio Genuardi
Journal:  Eur J Hum Genet       Date:  2013-01-30       Impact factor: 4.246

7.  Plantar vein thrombosis: a rare cause of plantar foot pain.

Authors:  Daniel S Siegal; Jim S Wu; Darren D Brennan; Tracy Challies; Mary G Hochman
Journal:  Skeletal Radiol       Date:  2007-12-05       Impact factor: 2.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.